Published on
February 10, 2026
- 08:30 GMT
Chugai and Araris Biotech AG Enter License Agreement for Araris' Linker-Payload ADC Technology AraLinQ®
TOKYO, JAPAN, February 10, 2026 /EINPresswire.com/ -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519, hereafter "Chugai") and Araris Biotech AG (hereafter "Araris") today announced that Chugai has exercised its option under the Research …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
